Riskpilot← Back to searchSign inGet full accessSilverudden Medical AB
ABActiveOrg 5592661192Herrhaga Gård 1General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2025
SEK 0
EBITDA margin
—
-52% vs 2024
Equity ratio
81.9%
Financial strength
Net profit 2025
SEK -2K
-59% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | -52% |
| Net profit | SEK -2K | -59% |
| Total assets | SEK 21K | -8% |
| Equity | SEK 18K | -10% |
| Employees | 0 | — |
Legal name
Silverudden Medical AB
Org number
5592661192
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 augusti 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet och läkartjänster, främst inom primärvård men även inom slutenvård. Företaget ska även bedriva verksamhet inom utbildning och författande, fortbildning samt friskvård. Bolaget ska förvalta och inneha aktier och värdepapper.
Address
Herrhaga Gård 1
Email
dianasylwander@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 47 | 0 | −0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 35 | −9 | −22 | −1 | −2 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 35 | −9 | −22 | −1 | −2 |
| Net financials | — | — | −0 | 0 | — |
| Profit before tax | 35 | −9 | −23 | −1 | −2 |
| Tax | −7 | — | — | — | — |
| Net profit | 27 | −9 | −23 | −1 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 69 | 53 | 25 | 23 | 21 |
| Equity | 52 | 43 | 21 | 19 | 18 |
| Long-term debt | — | — | — | — | — |
| Short-term debt | 16 | 10 | 4 | 4 | 4 |
| Total debt | 16 | 10 | 4 | 4 | 4 |
EBITDA margin
-190000.0%
This company
15.8%
Market median
-1202632% vs market
20212025
Equity ratio
81.9%
This company
38.2%
Market median
+114% vs market
20212025
Return on equity
-10.8%
This company
18.4%
Market median
-159% vs market
20212025
Net profit margin
-190000.0%
This company
8.1%
Market median
-2345779% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-06 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Silverudden Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Diana Louise Lindberg | Board of Directors | 0 companies |
| Herman Robert Sylwander | Deputy Board Member | 0 companies |